Seaport Global analyst Scott Graham reiterated a Buy rating on Badger Meter (BMI – Research Report) today and set a price target of $255.00.

Morgan Stanley analyst Michael Ulz raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $77 from $72 and keeps an Overweight ...

With the new round of announced tariffs, the demand side risk has increased notably', Stratas Advisors warned.

Schroder Investment Management Group boosted its stake in shares of Badger Meter, Inc. (NYSE:BMI – Free Report) by 74.4% in ...

Shares of Badger Meter, Inc. (NYSE:BMI – Get Free Report) have been given a consensus recommendation of “Hold” by the five research firms that are presently covering the stock, Ratings reports. Three ...

While pharma giants Novo Nordisk and Eli Lilly may have a solid hold on the obesity arena, Rhythm Pharmaceuticals is looking ...

Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Researchers surveyed 1,780 pregnant women across four European countries and found that half used fish oil and 10% used ...

Researchers conducted a randomized controlled trial in Tanzania to examine how switching between African heritage and Western ...

More than 55 million people worldwide have dementia, a number expected to nearly triple by 2050. Deaths from strokes may ...

OPEC+’s larger-than-expected supply increase for May is likely to widen the Brent-Dubai spread and bring more medium sour crude to the market, according to ING.

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...